In last trading session, ProKidney Corp (NASDAQ:PROK) saw 3.07 million shares changing hands with its beta currently measuring 1.43. Company’s recent per share price level of $0.77 trading at $0.12 or 19.50% at ring of the bell on the day assigns it a market valuation of $225.67M. That closing price of PROK’s stock is at a discount of -236.36% from its 52-week high price of $2.59 and is indicating a premium of 40.26% from its 52-week low price of $0.46.
For ProKidney Corp (PROK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.20. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
ProKidney Corp (NASDAQ:PROK) trade information
Upright in the green during last session for gaining 19.50%, in the last five days PROK remained trading in the red while hitting it’s week-highest on Wednesday, 06/18/25 when the stock touched $0.77 price level, adding 17.46% to its value on the day. ProKidney Corp’s shares saw a change of -69.16% in year-to-date performance and have moved -10.13% in past 5-day. ProKidney Corp (NASDAQ:PROK) showed a performance of 8.50% in past 30-days.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 84.6% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -289.61% in reaching the projected high whereas dropping to the targeted low would mean a loss of -289.61% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 9.74% while estimates for its earnings growth in next 5 years are of -2.31%.
ProKidney Corp (NASDAQ:PROK)’s Major holders
MORGAN STANLEY is the top institutional holder at PROK for having 14.45 million shares of worth $35.54 million. And as of 2024-06-30, it was holding 19.034 of the company’s outstanding shares.
The second largest institutional holder is SUVRETTA CAPITAL MANAGEMENT, LLC, which was holding about 9.34 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.306 of outstanding shares, having a total worth of $22.98 million.
